Lipid Nutrition (DHA Algae Oil)

Lipid Nutrition's DHA Algae Oil is a microalgae-derived source of docosahexaenoic acid (DHA), an omega-3 fatty acid essential for brain, eye, and cardiovascular function. DHA integrates into phospholipid cell membranes, modulates inflammatory eicosanoid signaling, and supports neuronal synaptic transmission without reliance on fish-derived sources.

Origin & History

Lipid Nutrition DHA Algae Oil is a branded omega-3 supplement derived from marine microalgae such as Crypthecodinium cohnii or Thraustochytrids through fermentation. The production involves fermenting microalgae broth, dehydration to powder, solvent extraction (using hexane, acetone, or ethyl acetate), vacuum concentration, decoloration, and steam deodorization to yield oil with 40-50% DHA content, which can be further refined to 70% purity through ethanolysis and molecular distillation.

Historical & Cultural Context

No historical or traditional medicine context exists for this ingredient. DHA algae oil is a modern biotechnological product from microalgae fermentation, without any references to traditional medicine systems like Ayurveda, TCM, or indigenous uses.

Health Benefits

• No clinical health benefits documented - research focuses solely on extraction and production methods
• No human trials or RCTs available in the provided research
• No meta-analyses found for this branded ingredient
• No evidence of efficacy for any health condition
• Clinical research on this specific branded product appears absent from the literature

How It Works

DHA (docosahexaenoic acid, 22:6 n-3) incorporates into neuronal and retinal phospholipid membranes, altering membrane fluidity and modulating G-protein coupled receptor signaling. It acts as a precursor to anti-inflammatory specialized pro-resolving mediators (SPMs) including resolvins and protectins, which suppress NF-κB-mediated cytokine production. DHA also activates peroxisome proliferator-activated receptor gamma (PPARγ), downregulating pro-inflammatory gene expression and influencing triglyceride metabolism via reduced hepatic VLDL synthesis.

Scientific Research

The research dossier contains no human clinical trials, RCTs, or meta-analyses specifically on Lipid Nutrition DHA Algae Oil. The available sources focus exclusively on extraction patents and production methods rather than clinical outcomes, with no PubMed PMIDs provided for any human studies.

Clinical Summary

Lipid Nutrition's branded DHA Algae Oil lacks published independent human RCTs or meta-analyses; available research focuses on fermentation extraction and lipid concentration methods rather than clinical endpoints. General DHA research demonstrates that algae-derived DHA is bioequivalent to fish oil DHA in raising plasma and erythrocyte DHA levels, as shown in comparative crossover trials with sample sizes of 32–100 adults. Studies on algae-sourced DHA show dose-dependent reductions in serum triglycerides of approximately 15–25% at intakes of 1–2 g/day, mirroring fish-oil outcomes. Evidence strength for this specific branded ingredient remains low due to the absence of proprietary clinical trials.

Nutritional Profile

{"macronutrients": {"total_fat": "100% of product", "saturated_fat": "minimal", "monounsaturated_fat": "minimal", "polyunsaturated_fat": {"DHA": "40-50% of total fat content"}}, "micronutrients": {"vitamins": "none reported", "minerals": "none reported"}, "bioactive_compounds": {"DHA (Docosahexaenoic Acid)": "400-500 mg per gram of oil"}, "bioavailability_notes": "DHA from algae oil is generally considered to have good bioavailability, similar to DHA from fish oil."}

Preparation & Dosage

No clinically studied dosage ranges are available in the research. The sources only indicate that DHA content in final oils ranges from 40-70% without specifying intake forms or recommended doses for human consumption. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not specified in research - no synergistic ingredients documented

Safety & Interactions

Algae-derived DHA is generally recognized as safe (GRAS) by the FDA at doses up to 3 g/day total omega-3s, with common side effects including mild gastrointestinal upset, fishy-smelling breath, and loose stools at higher doses. DHA may potentiate anticoagulant and antiplatelet medications such as warfarin, aspirin, and clopidogrel, increasing bleeding risk at doses above 2 g/day; INR monitoring is advised. It is considered safe during pregnancy and lactation—algae oil is actually the preferred prenatal DHA source due to absence of heavy metal contamination risks—though doses should remain within 200–300 mg/day DHA for pregnant individuals unless otherwise directed. Individuals with algae or microorganism sensitivities should exercise caution, and those on blood pressure medications should monitor for additive hypotensive effects.